1. Home
  2. CTXR vs KOPN Comparison

CTXR vs KOPN Comparison

Compare CTXR & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • KOPN
  • Stock Information
  • Founded
  • CTXR 2007
  • KOPN 1984
  • Country
  • CTXR United States
  • KOPN United States
  • Employees
  • CTXR N/A
  • KOPN N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • KOPN Semiconductors
  • Sector
  • CTXR Health Care
  • KOPN Technology
  • Exchange
  • CTXR Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • CTXR 84.9M
  • KOPN 85.7M
  • IPO Year
  • CTXR N/A
  • KOPN 1992
  • Fundamental
  • Price
  • CTXR $0.41
  • KOPN $0.78
  • Analyst Decision
  • CTXR Strong Buy
  • KOPN Strong Buy
  • Analyst Count
  • CTXR 2
  • KOPN 3
  • Target Price
  • CTXR $5.00
  • KOPN $2.67
  • AVG Volume (30 Days)
  • CTXR 1.1M
  • KOPN 2.0M
  • Earning Date
  • CTXR 08-12-2024
  • KOPN 11-07-2024
  • Dividend Yield
  • CTXR N/A
  • KOPN N/A
  • EPS Growth
  • CTXR N/A
  • KOPN N/A
  • EPS
  • CTXR N/A
  • KOPN N/A
  • Revenue
  • CTXR N/A
  • KOPN $41,545,194.00
  • Revenue This Year
  • CTXR N/A
  • KOPN $22.02
  • Revenue Next Year
  • CTXR N/A
  • KOPN $13.55
  • P/E Ratio
  • CTXR N/A
  • KOPN N/A
  • Revenue Growth
  • CTXR N/A
  • KOPN N/A
  • 52 Week Low
  • CTXR $0.34
  • KOPN $0.56
  • 52 Week High
  • CTXR $1.07
  • KOPN $2.82
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 38.61
  • KOPN 51.00
  • Support Level
  • CTXR $0.34
  • KOPN $0.71
  • Resistance Level
  • CTXR $0.41
  • KOPN $0.75
  • Average True Range (ATR)
  • CTXR 0.04
  • KOPN 0.04
  • MACD
  • CTXR 0.00
  • KOPN 0.01
  • Stochastic Oscillator
  • CTXR 36.59
  • KOPN 81.85

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: